Table 1 Demographic data and ELA for patients with MDD and healthy controls
| Â | Patients ( N= 40) | Controls ( N= 43) | Stat (P -value) |
|---|---|---|---|
Age (years) | 41.4 (10.9) | 37.0 (13.7) | t=1.6, df=1, 81, (P=0.1) |
Gender (female/male) | 24/16 | 25/18 | χ2=0.03, (P=0.86) |
Height (cm) | 171.9 (8.0) | 172.3 (10.4) | t=−0.19, df=1, 81, (P=0.85) |
Weight (kg) | 75.6 (15.1) | 70.9 (16.0) | t=1.4, df=1, 81, (P=0.18) |
Alcohol (units) | 3.9 (6.0) | 5.0 (6.2) | t=−0.8, df=1, 81, (P=0.40) |
Hamilton depression score | 28.0 (6.5) | 2.7 (2.9) | t=26.0, df=1, 81, (P<0.001) |
Childhood maltreatment total | 48.1 (21.7) | 31.1 (5.7) | t=4.9, df=1, 81, (P<0.001) |
Age of onset | 25.1 (12.4) | Â | Â |
Cumulative illness duration | 9.8 (10.1) | Â | Â |
Medication (free/SSRI /dual acting/valdoxan) | 11/14/15 | Â | Â |
Hippocampus left (ml) | 3.40 (0.49) | 3.65 (0.41) | F=6.4, df=1, 79, (P=0.013) |
Hippocampus right (ml) | 3.56 (0.50) | 3.81 (0.45) | F=5.8, df=1, 79, (P=0.019) |
Amygdala left (ml) | 1.62 (0.22) | 1.68 (0.23) | F=1.5, df=1, 79, (P=0.22) |
Amygdala right (ml) | 1.67 (0.20) | 1.70 (0.21) | F=0.3, df=1, 79, (P=0.57) |
CRP | 2.7 (3.0) | 1.4 (1.8) | Mann–Whitney U, ( Z=2.9, P=0.004) |
IL-6 | 13.3 (15.9) | 9.9 (14.8) | Mann–Whitney U, (Z=2.1, P=0.04) |
GILZ mRNA | 0.91 (0.24) | 0.99 (0.25) | Mann–Whitney U, (Z=1.4, P=0.16) |
SGK-1 mRNA | 0.96 (0.35) | 1.0 (0.37) | Mann–Whitney U, (Z=0.44, P=0.66) |
GR mRNA | 1.0 (0.25) | 1.0 (0.18) | Mann–Whitney U, (Z=0.36, P=0.72) |